DHODH: Dihydroorotate dehydrogenase (quinone), mitochondrial
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.
- Drugs that act on it: 6
- With a US drug page: 2
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Leflunomide | Approved | Dihydroorotate dehydrogenase inhibitor | Inhibitor | Boxed warning |
| Teriflunomide | Approved | Dihydroorotate dehydrogenase inhibitor | Inhibitor | Boxed warning |
| ASLAN-003 | — | Dihydroorotate dehydrogenase inhibitor | Inhibitor | — |
| Brequinar | — | Dihydroorotate dehydrogenase inhibitor | Inhibitor | — |
| Emvododstat | — | Dihydroorotate dehydrogenase inhibitor | Inhibitor | — |
| Vidofludimus | — | Dihydroorotate dehydrogenase inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Postaxial acrofacial dysostosis
- 0.83
- Familial hyperlipidemia
- 0.38
- Arthritic joint disease
- 0.37
- COVID-19
- 0.34
- Osteoarthritis, hip
- 0.31
- Glioblastoma
- 0.28
- Metabolic disease
- 0.27
- Coronary artery disorder
- 0.27
- Pneumonia
- 0.26
Drugs and mechanisms are from ChEMBL CHEMBL1966 (CC BY-SA 3.0). Gene name, function (UniProt Q02127, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets